FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sten Wingren

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Genes & Molecular Sequences

Genes, p53

Physiology

Co-author Network

Publications

TOP 3
Anna Göthlin Eremo; Bo Nordenskjöld; Olle Stål; Pia Wegman; Tommy Fornander; Sten Wingren
Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients.
Breezy Malakkaran Lindqvist; Sanja A Farkas; Sten Wingren; Torbjörn K Nilsson
DNA methylation pattern of the SLC25A43 gene in breast cancer.
Elisabet Tina; Pia Wegman; Marike Gabrielson; Breezy Malakkaran Lindqvist; Zelmina Lubovac; Sten Wingren
The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sten Wingren (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anna Göthlin Eremo; Bo Nordenskjöld; Olle Stål; Pia Wegman; Tommy Fornander; Sten Wingren
Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients.
Oncology reports 2013;29(4):1467-74.
2012: Breezy Malakkaran Lindqvist; Sanja A Farkas; Sten Wingren; Torbjörn K Nilsson
DNA methylation pattern of the SLC25A43 gene in breast cancer.
Epigenetics : official journal of the DNA Methylation Society 2012;7(3):300-6.
2012: Elisabet Tina; Pia Wegman; Marike Gabrielson; Breezy Malakkaran Lindqvist; Zelmina Lubovac; Sten Wingren
The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors.
BMC cancer 2012;12():350.
2011: Li Gao; Yaoquan Tu; Pia Wegman; Sten Wingren; Leif A Eriksson
A mechanistic hypothesis for the cytochrome P450-catalyzed cis-trans isomerization of 4-hydroxytamoxifen: an unusual redox reaction.
Journal of chemical information and modeling 2011;51(9):2293-301.
2009: Anna Lång; Pia Palmebäck Wegman; Sten Wingren
The significance of MDM2 SNP309 and p53 Arg72Pro in young women with breast cancer.
Oncology reports 2009;22(3):575-9.
2008: Barbara E Licznerska; Pia P Wegman; Bo Nordenskjöld; Sten Wingren
In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
Breast cancer research and treatment 2008;112(1):15-23.
2008: Piiha-Lotta Jerevall; Sara Brommesson; Carina Strand; Sofia Gruvberger-Saal; Per Malmström; Bo Nordenskjöld; Sten Wingren; Peter Söderkvist; Mårten Fernö; Olle Stål
Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.
Breast cancer research and treatment 2008;107(2):225-34.
2007: Pia Wegman; Sauli Elingarami; John Carstensen; Olle Stål; Bo Nordenskjöld; Sten Wingren
Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.
Breast cancer research : BCR 2007;9(1):R7.
2006: Pia Wegman; Olle Stal; Marie Stenmark Askmalm; Bo Nordenskjöld; Lars Erik Rutqvist; Sten Wingren
p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients.
Pharmacogenetics and genomics 2006;16(5):347-51.
2005: Malin Bergman; Marie Ahnström; Pia Palmebäck Wegman; Sten Wingren
Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women.
Journal of cancer research and clinical oncology 2005;131(7):439-44.
2005: Piiha-Lotta Jerevall; Ahmad Ahmadi; Malin Bergman; Olle Stål; Sten Wingren
Sulfotransferase1A1 and risk of postmenopausal breast cancer.
Anticancer research 2005;25(3c):2515-7.
2005: Pia Wegman; Linda Vainikka; Olle Stål; Bo Nordenskjöld; Lambert Skoog; Lars Erik Rutqvist; Sten Wingren
Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients.
Breast cancer research : BCR 2005;7(3):R284-90.
2002: Marie Sundquist; Sten Thorstenson; L Brudin; Sten Wingren; Bo Nordenskjöld
Incidence and prognosis in early onset breast cancer.
Breast (Edinburgh, Scotland) 2002;11(1):30-5.
2001: M Gentile; Marie Ahnström; F Schön; Sten Wingren
Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis.
Oncogene 2001;20(53):7753-60.
2001: M Bergman-Jungeström; Sten Wingren
Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women.
British journal of cancer 2001;85(6):859-62.
2001: M Gentile; A Wiman ; Sten Thorstenson; Niklas Loman; A Borg; Sten Wingren
Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer.
International journal of cancer. Journal international du cancer 2001;92(2):208-13.
2001: M Stenmark-Askmalm; M Gentile; Sten Wingren; O Ståhl
Protein accumulation and gene mutation of p53 in bilateral breast cancer. South-East Sweden Breast Cancer Group.
Acta oncologica (Stockholm, Sweden) 2001;40(1):56-62.
2000: M Agrup; Olle Stål; K Olsen; Sten Wingren
C-erbB-2 overexpression and survival in early onset breast cancer.
Breast cancer research and treatment 2000;63(1):23-9.
1999: M Bergman-Jungeström; M Gentile; A C Lundin; Sten Wingren
Association between CYP17 gene polymorphism and risk of breast cancer in young women.
International journal of cancer. Journal international du cancer 1999;84(4):350-3.
1999: M Gentile; M Bergman-Jungeström; K E Olsen; Peter Söderkvist; Sten Wingren
p53 and survival in early onset breast cancer: analysis of gene mutations, loss of heterozygosity and protein accumulation.
European journal of cancer (Oxford, England : 1990) 1999;35(8):1202-7.
1999: Avni Abdiu; Sten Wingren; SE Larsson; Ake Wasteson; TM Walz
Effects of human platelet-derived growth factor-AB on sarcoma growth in vitro and in vivo.
Cancer letters 1999;141(1-2):39-45.
1999: A C Lundin; Peter Söderkvist; B Eriksson; M Bergman-Jungeström; Sten Wingren
Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group.
Cancer research 1999;59(10):2332-4.
1999: M Gentile; K Olsen; M Dufmats; Sten Wingren
Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival.
British journal of cancer 1999;80(5-6):843-9.
1998: Avni Abdiu; TM Walz; B K Nishikawa; Sten Wingren; SE Larsson; Ake Wasteson
Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha and their receptors.
European journal of cancer (Oxford, England : 1990) 1998;34(13):2094-100.
1997: Sten Wingren; A van den Heuvel; M Gentile; K Olsen; Thomas Hatschek; Peter Söderkvist
Frequent allelic losses on chromosome 13q in human male breast carcinomas.
European journal of cancer (Oxford, England : 1990) 1997;33(14):2393-6.
1997: P Rosenberg; Sten Wingren; C Guerrieri
Flow cytometric DNA-heterogeneity in paraffin-embedded endometrial cancer.
Acta oncologica (Stockholm, Sweden) 1997;36(1):23-6.
1996: M Karlsson; B Boeryd; John Carstensen; B Frånlund; B Gustafsson; B Kågedal; Xiao-Feng Sun; Sten Wingren
Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):357-62.
1996: M Karlsson; U Jungnelius; Steinar Aamdal; B Boeryd; John Carstensen; B Kågedal; Ronny Westberg; Sten Wingren
Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma.
International journal of cancer. Journal international du cancer 1996;65(1):1-5.
1995: Olle Stål; S Sullivan; Sten Wingren; L Skoog; Lars Erik Rutqvist; John Carstensen; Bo Nordenskjöld
c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(13-14):2185-90.
1995: Sten Wingren; C Guerrieri; B Frånlund; Olle Stål
Loss of cytokeratins in breast cancer cells using multiparameter DNA flow cytometry is related to both cellular factors and preparation procedure.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1995;9(3):229-33.
1995: Sten Wingren; Olle Stål
Flow cytometric gating on cytokeratin-containing DNA aneuploid breast cancer cells improves the prediction of recurrence.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1893-5.
1995: TM Walz; C Malm; B K Nishikawa; K Willander; Sten Wingren; Ake Wasteson
Production of transforming growth factor alpha by human leukemia cells (HL-60 and U-937) during monocytic differentiation.
Leukemia 1995;9(4):671-6.
1995: M Karlsson; B Boeryd; John Carstensen; B Kågedal; Sten Wingren
DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas.
British journal of cancer 1995;71(1):177-81.
1995: Olle Stål; M Stenmark Askmalm; Sten Wingren; Lars Erik Rutqvist; L Skoog; L Ferraud; S Sullivan; John Carstensen; Bo Nordenskjöld
p53 expression and the result of adjuvant therapy of breast cancer.
Acta oncologica (Stockholm, Sweden) 1995;34(6):767-70.
1994: Olle Stål; L Skoog; Lars Erik Rutqvist; John Carstensen; Sten Wingren; S Sullivan; A C Andersson; M Dufmats; Bo Nordenskjöld
S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.
British journal of cancer 1994;70(6):1258-62.
1994: C Guerrieri; T Högberg; Sten Wingren; S Fristedt; E Simonsen; B Boeryd
Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
Cancer 1994;74(8):2329-40.
1994: Sten Wingren; Olle Stål; S Sullivan; A Brisfors; Bo Nordenskjöld
S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer.
International journal of cancer. Journal international du cancer 1994;59(1):7-10.
1994: Olle Stål; S Sullivan; Xiao-Feng Sun; Sten Wingren; Bo Nordenskjöld
Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
Cytometry 1994;16(2):160-8.
1994: Sten Wingren; Olle Stål; Bo Nordenskjöld
Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group.
British journal of cancer 1994;69(3):546-9.
1994: M Karlsson; B Boeryd; John Carstensen; B Kågedal; Sten Wingren
DNA ploidy and S-phase fraction in primary melanomas and their regional metastases.
Melanoma research 1994;4(1):47-51.
1994: Sten Wingren; Olle Stål; John Carstensen; Xiao-Feng Sun; Bo Nordenskjöld
S-phase determination of immunoselected cytokeratin-containing breast cancer cells improves the prediction of recurrence.
Breast cancer research and treatment 1994;29(2):179-87.
1994: L Vavruch; S Eneström; John Carstensen; Bo Nordenskjöld; Sten Wingren
DNA index and S-phase in primary brain tumors. A comparison between fresh and deparaffinized specimens studied by flow cytometry.
Journal of neurosurgery 1994;80(1):85-9.
1994: Olle Stål; John Carstensen; Sten Wingren; Lars Erik Rutqvist; L Skoog; C Klintenberg; Bo Nordenskjöld
Relationship of DNA ploidy and S-phase fraction to survival after first recurrence of breast cancer.
Acta oncologica (Stockholm, Sweden) 1994;33(4):423-9.
1994: Thomas Hatschek; Sten Wingren; John Carstensen; Ragnar Hultborn
DNA content and S-phase fraction in male breast carcinomas.
Acta oncologica (Stockholm, Sweden) 1994;33(6):609-13.
1993: Olle Stål; M Dufmats; Thomas Hatschek; John Carstensen; C Klintenberg; Lars Erik Rutqvist; L Skoog; S Sullivan; Sten Wingren; Bo Nordenskjöld
S-phase fraction is a prognostic factor in stage I breast carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1717-22.
1993: M Karlsson; B Boeryd; John Carstensen; B Kågedal; A T Bratel; Sten Wingren
DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease.
British journal of cancer 1993;67(1):134-8.
1992: Xiao-Feng Sun; John Carstensen; H Zhang; Olle Stål; Sten Wingren; Thomas Hatschek; Bo Nordenskjöld
Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.
Lancet 1992;340(8832):1369-73.
1991: TM Walz; Avni Abdiu; Sten Wingren; S Smeds; S E Larsson; Ake Wasteson
Suramin inhibits growth of human osteosarcoma xenografts in nude mice.
Cancer research 1991;51(13):3585-9.
1991: Xiao-Feng Sun; Sten Wingren; John Carstensen; Olle Stål; Thomas Hatschek; B Boeryd; Bo Nordenskjöld; H Zhang
ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.
European journal of cancer (Oxford, England : 1990) 1991;27(12):1646-9.
1991: Xiao-Feng Sun; Thomas Hatschek; Sten Wingren; Olle Stål; John Carstensen; H Zhang; B Boeryd; R Sjödahl; Bo Nordenskjöld
Ras p21 expression in relation to histopathological variables and prognosis in colorectal adenocarcinoma.
Acta oncologica (Stockholm, Sweden) 1991;30(8):933-9.
1989: Olle Stål; Sten Wingren; John Carstensen; Lars Erik Rutqvist; L Skoog; C Klintenberg; Bo Nordenskjöld
Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.
European journal of cancer & clinical oncology 1989;25(2):301-9.
1988: A L Hostetter; J Hrafnkelsson; Sten Wingren; S Enestrom; Bo Nordenskjöld
A comparative study of DNA cytometry methods for benign and malignant thyroid tissue.
American journal of clinical pathology 1988;89(6):760-3.
1988: Sten Wingren; Thomas Hatschek; Olle Stål; B Boeryd; Bo Nordenskjöld
Comparison of static and flow cytofluorometry for estimation of DNA index and S-phase fraction in fresh and paraffin-embedded breast carcinoma tissue.
Acta oncologica (Stockholm, Sweden) 1988;27(6b):793-7.